Stanford Child Neurology Division - Our Team
Dr. Paul Graham Fisher is Professor of Neurology, Pediatrics, and by courtesy, Neurosurgery, Epidemiology and Population Health, and Human Biology; Division Chief of Child Neurology; Senior Vice Chair for Academic Affairs, Department of Neurology; the Dunlevie Family University Fellow in Undergraduate Education; and Co-Director of the Center for Brain and Behavior at Stanford University and Lucile Salter Packard Children’s Hospital. Dr. Fisher received his B.A. with Distinction at Stanford and M.D. at the University of California, San Francisco, before completing residencies in pediatrics and neurology at the Johns Hopkins Hospital and then a fellowship in neuro-oncology at Children’s Hospital of Philadelphia and Johns Hopkins. He also obtained a master’s degree in epidemiology at Johns Hopkins University.
After starting out on the faculty at Hopkins, Dr. Fisher was recruited in 1997 back to Palo Alto, where he started the pediatric neuro-oncology program at Stanford. His clinical work and research focus on epidemiology, therapy, and late effects of childhood brain tumors, and he has authored over 300 scholarly publications on these and other neurology topics. Dr. Fisher is a co-investigator in the National Cancer Institute’s Pediatric Brain Tumor Consortium and National Institutes of Health’s Undiagnosed Diseases Network. At Stanford he teaches the popular undergraduate classes “Cancer Epidemiology” and “The Human Organism” in Human Biology.
Dr. Fisher is an Associate Editor for The Journal of Pediatrics, and serves on the editorial boards of Journal of Clinical Oncology and Journal of Neuro-Oncology. In 2021, he was elected to the COPE Council of the Committee on Publication Ethics, and he has interests in plagiarism, text-recycling, and the editorial process. He is a Fellow of both the American Academy of Pediatrics and the American Academy of Neurology, and an active member of the Child Neurology Society, Professors of Child Neurology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, Brain Tumor Epidemiology Consortium, and American Academy of Pediatrics. In addition, Dr. Fisher is presently on the Advisory Boards of Greater Bay Area Make-A-Wish and There With Care.
Dr. Fisher’s personal interests are his wife Joy and three grown children, along with downhill skiing, anything baseball, casual biking, guitar playing, bad golf, travel with intense picnicking, and his dogs Monkey, Chloe, and Mona.
Dr. Fiona Baumer is Instructor in Neurology at Stanford University with a focus on pediatric epilepsy. Dr. Baumer received her B.A. at Stanford University and her M.D. from Harvard Medical School. She remained on the east coast to train in pediatrics and child neurology at Boston Children’s Hospital before returning to Stanford in 2015 for epilepsy training as the first Maggie Otto Fellow in Pediatric Epilepsy. She joined the neurology faculty in 2016.
Dr. Baumer’s clinical and research interests include difficult to treat pediatric epilepsies and the interaction between epilepsy and cognition. She is gaining expertise in noninvasive brain stimulation as a clinical and research tool in epilepsy. Dr. Baumer is currently participating in the KL2 Mentored Research Fellowship through which she will conduct a study using transcranial magnetic stimulation to assess cortical excitability and synaptic plasticity in benign epilepsy with centrotemporal spikes (Rolandic Epilepsy).
Outside work, Dr. Baumer enjoys hiking, camping, and letterboxing throughout the Bay Area as well as visiting family and friends near and far. She and her husband recently welcomed their first daughter.
Dr. Shannon Beres is a Clinical Assistant Professor of Neurology in Neurology at Stanford University. Dr. Beres received her B.S. at the University of California, Los Angeles, and M.D. at the Medical College of Virginia. She completed her pediatrics and neurology residencies at the University of California, San Francisco. She then completed further specialization with a pediatric and adult neuro-ophthalmology fellowship at the Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia. Her interests in pseudotumor cerebri syndrome, optic neuritis, optic glioma, and eye movement abnormalities were extended by research in these areas. Dr. Beres joined the faculty at Stanford in 2015 as a child neurologist with a special interest in neuro-ophthalmology.
Dr. Beres’ personal interests revolve around her husband, two young daughters, and family. She enjoys being outdoors, swimming, soccer, traveling, and musicals. No day is complete without a little costume dance party with her two girls before bed.
Dr. Cynthia Campen is a Clinical Associate Professor in Neurology at Stanford University. She received her B.S. from University of California, Davis, and her M.D. from University of California, San Francisco, where she completed her residency in pediatrics. She then left the Bay Area briefly for her child neurology residency at the Children's Hospital of Philadelphia. She returned to California for her fellowship in pediatric neuro-oncology at Lucile Packard Children’s Hospital, during which she also completed a master’s degree in epidemiology. Dr. Campen now attends in child neurology and pediatric neuro-oncology and has a clinical interest in neurofibromatosis type I. She is also the Program Director for Child Neurology Residency.
Dr. Campen’s research interests include epidemiology of childhood brain tumors, late effects of brain tumor treatments, intracranial vasculopathy, and neurofibromatosis. She is an active member of the American Academy of Neurology, Child Neurology Society, American Society of Clinical Oncology, Children’s Oncology Group, and Society for Neuro-Oncology.
Outside work, Dr. Campen enjoys spending time with friends and family, hiking and camping in beautiful Northern California, cooking, knitting, listening to live music, and cheering on the Oakland Raiders, Athletics, and Warriors while playing with her twins.
Dr. John Day, a Stanford Professor of Neurology, Pediatrics, and Pathology, trained initially in neurology with the goal of understanding brain function and disease, but ultimately chose a path into the more definable and dissectible world of neuromuscular disease. In 2011 he was recruited back to the Bay Area to head the integrated Lucile Packard Children’s Hospital, Stanford Hospital, and Stanford University Neuromuscular Program, coordinating comprehensive patient care with basic, translational and clinical research for muscular dystrophy, spinal muscular atrophy, amyotrophic lateral sclerosis, and related disorders. In his own research focused on identifying genetic causes and defining molecular pathophysiology, Dr. Day works at the interface of comprehensive clinical care and the development of novel therapeutic approaches for these fatal disorders.
After majoring in physics at Oberlin College, Dr. Day received his medical training at the University of Minnesota before completing a graduate program in neuroscience at the Albert Einstein College of Medicine. After a neurology residency at University of California, San Francisco, he completed a clinical neurophysiology and neuromuscular fellowship before returning to Minnesota to establish a neuromuscular program. During the next 20 years Dr. Day founded and expanded the Paul and Sheila Wellstone Muscular Dystrophy Center at the University of Minnesota, providing comprehensive care for patients, while creating an integrated consortium for clinical, basic and translational research on neuromuscular disorders. As head of the Wellstone Center, Dr. Day was a Professor of Pediatrics and Neurology and cared for neuromuscular patients of all ages, while also directing both a CLIA-certified neuromuscular pathology laboratory, and a clinical neurophysiology training program.
In 2011, Dr. Day moved to Stanford to expand the neuromuscular division, integrating Stanford’s strength in basic science with the unique clinical opportunities of Northern California, and again emphasizing the importance of combining excellence in patient care, collaborative research, and training opportunities for clinicians and investigators. Working with the excellent established neuromuscular faculty, and recruiting additional pediatric and adult neuromuscular neurologists, the Packard-Stanford Neuromuscular Program is already an important contributor in the worldwide effort to combat these disorders.
Dr. Day lives with Suzanne Degler, his wife of decades, two children – Nick (when he visits home) and Ibby, a student in Palo Alto.
Dr. Dawn C. Duane is Clinical Associate Professor of Neurology at Stanford University. Dr. Duane received her B.S. from the University of California, Berkeley, and her M.D. from Wayne State University in Detroit, Michigan. Prior to medical school, she worked for Kaiser Permanente’s Division of Research and pursued epidemiological research in conjunction with the California Department of Health. While in medical school, Dr. Duane obtained a master’s degree in public health from the University of Michigan, Ann Arbor. She later completed her residencies in pediatrics and neurology at St. Joseph’s Hospital and the Barrow Neurological Institute in Phoenix, Arizona.
After residency, Dr. Duane returned to the Bay Area and joined the child neurology faculty at Stanford. Now she coordinates both the child neurology resident continuity clinic and the neuropsychopharmacology clinic, a joint child neurology and child psychiatry effort, which Dr. Duane established. Dr. Duane is the Medical Director of the child neurology outpatient clinics and also leads general neurology clinics four days a week.
Dr. Duane lives in Cupertino, with her three children, Kazmiera, T.J., and Max. When Dr. Duane is not being a doctor or mother, she enjoys reading, swimming, relaxing with neighbors, and creating theme parties (famous in resident continuity clinic!).
Dr. William Gallentine is a Clinical Professor of Neurology at Stanford University. A product of Waynesburg University, he subsequently received his D.O. from the Philadelphia College of Osteopathic Medicine and then completed a pediatrics residency at Geisinger Medical Center. Dr. Gallentine next undertook his child neurology residency and clinical neurophysiology fellowship at Duke University, where he remained on the faculty as a pediatric epileptogist for 11 years, prior to being recruited to Stanford in 2018.
Dr. Gallentine’s research interests focus on the role of inflammation and genetics in the development of epilepsy, and the ovelap between the two. He is part of a NIH funded multi-center study aimed at discovering novel biomarkers of epileptogenesis and identifying potential therapeutic targets within the inflammatory cascade as a new approach to treating and preventing epilepsy. He is also interested in the exploration of novel mutation-specific therapeutics for children with genetic epilepsies.
Dr. Gallentine’s clinical interests focus on children with refractory epilepsy. He offers clinical expertise in all aspects of epilepsy management, including medications, dietary therapy, surgical planning, and neurostimulation. He has developed specific interests in autoimmune and genetic epilepsies. His epilepsy and inflammation clinic focuses on children with antibody-mediated autoimmune epilepsy (including NMDA receptor encephalitis), Rasmussen’s encephalitis, recurrent febrile seizures, febrile status epilepticus, genetic epilepsies with seizures triggered by fever (Dravet syndrome , GEFS+), fever-induced refractory epileptic encephalopathy (FIRES), mesial temporal temporal lobe epilepsy, and infantile spasms. His epilepsy and genetics clinic provides multi-disciplinary care focused on the evaluation and management of children with known or suspected genetic epilepsy syndromes with an emphasis on mutation-specific therapy.
At Stanford he serves as the Outpatient Medical Director of Pediatric Epilepsy. He is an active member of the American Clinical Neurophysiology Society, American Epilepsy Society, and American Academy of Neurology. Dr. Gallentine has a passion for teaching, too. During his tenure at Duke, he played a prominent role in medical education serving as the Child Neurology Residency Program Director.
When not working, Dr. Gallentine is always up for seeking a new travel adventure with his wife Darla and kids, Caleb, Anya, and Gabe. They definitely consider themselves “foodies,” always looking to try a new dish. He enjoys watching anything sports related, with San Jose Sharks hockey being his most recent obsession.
Dr. Jin S. Hahn is Professor of Neurology and Pediatrics at Stanford. He attended Harvard College and Medical School, and then completed pediatrics and neurology residencies at The Children’s Hospital in Boston.
Dr. Hahn’s clinical research interests include congenital brain malformations, neonatal seizures, and fetal neurology. With the perinatologists and neonatologists, he plays a key role in the Center for Comprehensive Fetal Health & Maternal and Family Care. Through this center he participates in a prenatal neurology consult program.
Dr. Hahn is also a Silicon Valley “techie.” He is a Medical Director of Clinical Informatics Program at Lucile Packard Children’s Hospital, and has helped implement its Epic Electronic Health Record.
When he is not with his wife and two daughters, he enjoys bicycling around the Bay Area, both road and mountain. He knows that this is one of the best areas in the country for cycling, and can always point out the best mountains, coastline, bayshore, and foothills to enjoy.
Dr. Jonathan Hecht is an Adjunct Clinical Assistant Professor in Neurology at Stanford University. Dr. Hecht received his B.S. from the University of California, Irvine. He then completed an M.D. and Ph.D. at the University of California, San Diego. His Ph.D. training and research was in the area of developmental neuroscience, focusing on development of the cerebral cortex. Dr. Hecht then completed a residency in pediatrics at the University of California, San Francisco. After working as a pediatrician in the community, he then returned to UCSF and completed a residency in child neurology. Following his neurology training, he remained at UCSF and did postdoctoral research focusing on the interaction between the meninges and brain in development.
After finishing his postdoctoral fellowship, he moved to Washington, DC, where he joined the faculty at Children's National Medical Center. Fearing the weather, he then returned to California and worked at Children's Hospital Los Angeles. He finally returned to the beautiful Bay Area to join the child neurology faculty at Stanford in 2014. Dr. Hecht now has a busy full-time, general child neurology practice in the East Bay, where he attends at John Muir Medical Center, as well as Lucile Packard Children's Hospital, where he is able to teach residents and medical students. Dr. Hecht feels that his research experiences have been extremely valuable allowing him to interpret neurological research, and to apply new information to help the care of his young patients.
Dr. Hecht lives in Oakland. Outside work, he enjoys fixing his golf slice, making Texas barbecue, baseball, and enjoying life in the Bay Area with friends and family.
Dr. Ann Hyslop is a Clinical Associate Professor Neurology at Stanford University. She received her B.A. at Macalester College and M.D. at the University of Texas in Houston. She then completed her pediatrics residency at the Mount Sinai Hospital in New York City and child neurology residency at the University of Washington in Seattle. She next completed a clinical neurophysiology fellowship at Miami Children's Hospital after which she had further training in the pre-surgical evaluation of medically intractable epilepsy. She remained as a pediatric epileptologist at Miami Children's Hospital with a concentration in surgical epilepsy for 10 years before joining Stanford in 2022.
Dr. Hyslop is an avid diver, seeking out shark dives worldwide, and loves yoga, sailing, and traveling with her husband.
Dr. Susy Jeng is Clinical Associate Professor of Neurology at Stanford University. She received her B.A. at Harvard College and M.D. at the University of California, San Diego. She completed her pediatrics residency at University of California, San Francisco and is board-certified in pediatrics. After practicing general pediatrics for two years, she returned to UCSF for neurology residency.
Upon completion of her residencies, she joined the faculty at Stanford as a child neurologist with a special interest in medical education. In particular, she enjoys serving as director of Stanford child neurology medical student clerkships and as the pediatric education leader in neurology for the Stanford pediatrics residency. She has been an active educator in the community, lecturing about child neurology to pediatricians throughout the Bay Area, as well as nationally, through the American Academy of Pediatrics. She is also a member of the American Academy of Neurology, Child Neurology Society, and American Headache Society.
Dr. Jeng’s personal interests are centered around her husband, Yee-Li, and their two young children. When there is time and energy left over, she enjoys discovering cheap/good eats and drinks in San Francisco and reading adult and children’s literature.
Dr. Hyunmi Kim is Clinical Professor of Neurology at Stanford University. She received her M.D. and Ph.D. from Ewha Womans University in Seoul, Korea. She completed her residency in Pediatrics at Asan Medical Center and fellowship in Pediatric Neurology at Ewha Womans University Hospital and Seoul National University Hospital in Seoul, Korea. In the United States, she completed her child neurology residency at Medical College of Georgia and epilepsy fellowship at the Cleveland Clinic. She obtained her MPH from University of Alabama at Birmingham while she was the faculty there. She was a faculty and director of pediatric epilepsy center at Emory University, before joining at Stanford University. She is board certified in child neurology, clinical neurophysiology, and epilepsy.
Dr. Kim’s clinical expertise is epilepsy, treatment-resistant epilepsy, and epilepsy surgery including stereo EEG monitoring and neurostimulation. Dr. Kim’s research interests are multimodal brain imaging and neurophysiologic data analysis to delineate seizure onset foci and propagation networks. She has also established a line of population health research exploring risk factors, treatment pattern, and outcomes in people with epilepsy. She is an active member of American Epilepsy Society (AES) and American Academy of Neurology (AAN).
Dr. Kim’s personal interests are exploring the National Parks and golfing.
Dr. Jenna Klotz is Clinical Assistant Professor of Neurology at Stanford University. She received a B.S. in physics and French literature from the College of William and Mary. She later completed her M.S. in physiology at University of Cincinnati, where she also earned her M.D. She then completed residencies in pediatrics and child neurology at Stanford. In her last year she was chief resident and lauded for her teaching. Subsequently Dr. Klotz completed a clinical neurophysiology fellowship at Stanford with a focus on neuromuscular medicine. She joined the Stanford faculty in 2018. Currently, she sees a variety of patients in general child neurology clinic and also works as part of the multidisciplinary pediatric neuromuscular team. She also performs pediatric EMG/nerve conduction studies.
Jenna lives in Redwood City with her husband, Arek, and their son, Arthur. She likes to spend her weekends taking exercise classes followed immediately by brunch and playing cooperative board games. She loves taking her son Arthur to swimming class and the park.
Dr. Juliet Knowles is Assistant Professor in Neurology, and specializes in epilepsy. She received her B.A. with a double major in Microbiology and Philosophy at the University of Texas-Austin. She then completed her M.D. and Ph.D. in Neurosciences at Stanford University. In graduate school, Dr. Knowles conducted research on novel neurotrophin-based small molecules for the treatment of Alzheimer’s disease under the mentorship of chair Dr. Frank Longo. After deciding to become a pediatric neurologist, Dr. Knowles completed her residencies in Pediatrics and Child Neurology at Stanford, where she also served as Chief Resident in Neurology. Following this, she completed a Pediatric Epilepsy fellowship, also at Stanford.
Currently Dr. Knowles cares for patients with pediatric epilepsy, and is particularly interested in genetic epilepsy and difficult to treat, or refractory, epilepsy. Dr. Knowles has developed a basic and translational research program under the mentorship of Drs Michelle Monje, John Huguenard and Courtney Wusthoff, and she is focused on how recurrent seizures influence brain development in pediatric epilepsy, as well as the mechanisms underlying epileptogenesis and associated cognitive dysfunction. Her current projects are particularly focused on interactions between neurons (gray matter) and myelin (white matter). Dr. Knowles’s research is supported by the American Epilepsy Society, a NIH/NINDS K12 award, the CURE Epilepsy Foundation, the Child Neurology Foundation/Pediatric Epilepsy Research Foundation and the Stanford Child Health Research Institute.
When she is not in the clinic or the lab, Dr. Knowles loves to spend time with her husband, Joshua, and their two children. She also enjoys reading, training and running in marathons, and spending time in the great outdoors of California.
Dr. Sarah Lee is Clinical Assistant Professor in Neurology at Stanford University. She received a B.A. in comparative literature from Columbia University and worked at The Paris Review and Random House before returning to Columbia to complete the post-baccalaureate premedical program in 2003. She received her M.D. from Albert Einstein College of Medicine, where she graduated with special distinction in neurology, and went on to complete her child neurology residency at Stanford, followed by a neurovascular fellowship at the Stanford Stroke Center. She attends on both the child neurology service as well as the adult stroke service. Her main clinical and research focus involves optimizing diagnosis, treatment, and rehabilitation for pediatric and young adult stroke patients. Additional areas of particular interest include venous sinus thrombosis, inflammatory and non-inflammatory vasculopathies, stroke in pregnancy, and aphasia.
In her free time, Sarah enjoys reading, watching old movies, eating ice cream, and spending time outdoors with her husband Kevin and two sons, Archer and Cameron.
Lauren Mattas, M.S., C.G.C, completed her training Genetic Counseling at the Icahn School of Medicine at Mount Sinai in 2014, and was certified by the American Board of Genetic Counseling that same year. She began her career at the Mills Peninsula Dorothy Schneider Cancer Center in San Mateo, providing cancer genetics counseling. She then practiced at Kaiser Permanente in Oakland and supported wide spectrum of patients in cancer, prenatal, and pediatric and adult general genetics. Lauren came to Lucile Packard Children’s Hospital at Stanford in the Pediatric Neurogenomics Program in 2020. Since that time, she has specialized in providing care for children with rare neurological conditions, including epilepsy, leukodystrophy, brain malformations, and movement disorders. She has been very involved in supervising and teaching graduate students, and providing mentorship to future genetic counselors.
Dr. Elizabeth Mayne is an Instructor in Neurology with a focus in pediatric neurocritical care and stroke. She received her B.S. in biological sciences at Stanford. She was awarded a Rhodes Scholarship to study at Oxford University, where she earned a Ph.D. in physiology. Her graduate work in Professor Ole Paulsen’s lab focused on diffuse neuromodulatory regulation of cortical network oscillations. Following her graduate work, she received her M.D. from Harvard Medical School through the joint Harvard-MIT Program in Health Sciences and Technology. She then returned to Stanford for her pediatrics and child neurology residencies. After residency, she completed a clinical fellowship in pediatric neurocritical care at Lurie Children’s Hospital in Chicago before returning to Stanford to continue her research on pediatric stroke, which is supported by a NIH-NINDS K12 award.
Dr. Mayne is working with Dr. Marion Buckwalter to investigate the long-term cognitive consequences of pediatric stroke. Strokes increase the birth of new brain cells (neurogenesis), but also result in long-term inflammation in the brain. In adults, this stroke-induced chronic inflammation increases the risk of dementia, but its consequences in children are unknown. Using animal models of pediatric stroke, Dr. Mayne seeks to understand how neurogenesis and inflammation interact to affect cognitive development after stroke in childhood. In addition to pediatric stroke, Dr. Mayne’s clinical interests include neuroprotection and prognostication after cardiac arrest, multimodal neuromonitoring, and neurologic care of children with congenital cardiac disease.
When not in the lab or hospital, Dr. Mayne enjoys hiking, cycling, cooking (mis)adventures, and spending time with her family and her two young nieces.
Dr. Chris Lee-Messer is a Clinical Assistant Professor in Neurology at Stanford University. Dr. Lee-Messer received his B.A. at Harvard University and M.D. and Ph.D. at Washington University in St. Louis. He completed an internship in pediatrics at the University of California, San Francisco, before completing residency in child neurology at Stanford and Lucile Packard Children's Hospital. He has also completed an epilepsy fellowship at Stanford.
Dr. Lee-Messer's research has focused on the role of neuronal microcircuits in information processing and development, and he has conducted postdoctoral research in optogenetics in the laboratory of Professor Karl Deisseroth in the departments of Bioengineering and Psychiatry at Stanford. He now works as a member of the pediatric epilepsy and general child neurology groups.
Dr. Lee-Messer enjoys spending time with his wife, Jessica, and his son Beckett. His hobbies include running, volunteering at his son's school, and promoting the use of the python programming language in science and education.
Dr. Katherine Mackenzie is a Clinical Associate Professor of Neurology at Lucile Packard Children’s Hospital of Stanford University.
Dr. Mackenzie received her B.A. with honors from Stanford and her M.D. from the University of California, Irvine. She trained in pediatrics at Kaiser Permanente, Los Angeles. She then went on to train in child neurology at Stanford University and Lucile Packard Children's Hospital. Following residency, she completed a fellowship in movement disorders at Stanford under the aegis of Dr. Helen Bronte-Stewart, and followed that with a fellowship focused on pediatric movement disorders with Dr. Jonathan Mink at the University of Rochester.
Dr. Mackenzie directs the Packard movement disorders clinic, focusing on disorders such as dystonia, chorea, tremor, ataxia, tics, and Tourette Syndrome. She is a member of the Child Neurology Society and the Movement Disorders Society.
Outside of work, Dr. Mackenzie enjoys hiking, baking, exploring the world, learning new languages, and spending time with her growing family.
Michelle Monje, MD, PhD, is a Professor of Neurology and, by courtesy, of Neurosurgery, Pathology, and Pediatrics. Dr. Monje received her M.D. and Ph.D. in Neuroscience from Stanford University. As a Ph.D. student under the mentorship of Dr. Theo Palmer, Dr. Monje studied microenvironmental determinants of neural stem cell fate choice. She discovered that brain inflammation prevents neuronal differentiation of neural stem cells, work that has proven seminal in understanding the behavior of neural stem cells in disease states and the potential of neural stem cells in regenerative medicine.
Dr. Monje completed her residency training in neurology at the Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School Partners program, and then returned to Stanford for a clinical fellowship in pediatric neuro-oncology and a post-doctoral fellowship with Dr. Philip Beachy. During her postdoctoral work, Dr. Monje focused on the neurodevelopmental origins of a devastating pediatric brain tumor called diffuse intrinsic pontine glioma (DIPG) - the most fatal cancer in children. Her work on this topic resulted in identifying a previously unrecognized brainstem neural precursor cell population that is the putative cell of origin for DIPG. Dr. Monje also established new in vitro and in vivo models for studying the disease and identified important molecular targets of therapy.
The Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states. Areas of emphasis include neuron-glial interactions, and microenvironmental contributions to glioma pathogenesis. As a practicing neurologist and neuro-oncologist, Dr. Monje is particularly interested in the roles for neural precursor cell function and dysfunction in the origins of pediatric brain tumors and the neurological consequences of cancer treatment.
Outside work, Dr. Monje spends her time with her husband Karl, sons Cole, Alexander and Hudson and daughter Emma. She enjoys running, cooking, playing with the family dog, and exploring the area's parks, libraries, museums and zoos with her family.
Dr. Miguel Moreno is Clinical Associate Professor of Neurology at Stanford, with a practice in general child neurology. After taking his M.D. at Howard University College of Medicine, he trained in child neurology at the University of California, Irvine. He worked previously at Santa Clara Valley Medical Center. Today he sees a variety of conditions including migraines/headaches, epilepsy, concussion, developmental delays, and cerebral palsy. He has a particular interest in using intramuscular botulinum toxin injections to treat spasticity. Dr. Moreno enjoys teaching medical students, residents, and fellows in hospital rounds and in clinic.
Dr. Moreno is a Northern California native who attended college at San Jose State University. He is proud to help families and children in the surrounding communities of the Bay Area. His outside interests include the occasional 5K runs, taking his family to outdoor festivals, and participating in traditional Mexica Danza.
Dr. Jennifer O’Malley is Clinical Assistant Professor of Neurology at Lucile Packard Children’s Hospital of Stanford University. After receiving her B.S. in biology and B.A. in Spanish at Case Western Reserve University in Cleveland, Dr. O’Malley completed her M.D. and Ph.D. in neuroscience through the Medical Scientist Training Program at the University of Cincinnati College of Medicine. She then completed her pediatrics and child neurology residencies at Cincinnati Children’s Hospital Medical Center, before being recruited to Stanford.
Dr. O’Malley has longstanding clinical and research interests in movement disorders. Her Ph.D. dissertation research focused on understanding underlying mechanisms of treatment-related dyskinesias. Dr. O’Malley is passionate about improving therapeutic options for children with movement disorders. She has a particular clinical interest in evaluation and treatment of children with dystonia, and is working with other Stanford movement disorders faculty to develop a pediatric deep brain stimulation program.
Jennifer lives in San Francisco, with her husband Matt. Together, they enjoy cooking, hiking, yoga, and scuba diving.
Dr. Sonia Partap is Clinical Professor of Neurology at Stanford University, and a neuro-oncologist at Lucile Salter Packard Children’s Hospital at Stanford. Dr. Partap received both her B.A. and M.D. at the University of Missouri, Kansas City, before completing residencies in pediatrics and neurology at Brown University and University of Washington, respectively. She then came to Stanford in 2006 as the first Beverly and Bernard Wolfe Fellow in Pediatric Neuro-Oncology. In 2009 she completed a master's degree in Epidemiology at Stanford. Her research interests include epidemiology, international health, early stage trials in neuro-oncology, and late effects of therapy. Dr. Partap attends in both child neurology and pediatric neuro-oncology and is Fellowship Director for pediatric neuro-oncology.
Dr. Partap was elected to the Child Neurology Society's Board of Directors as Councillor of the West. She is also an active member of the American Academy of Pediatrics' Section on Neurology, American Academy of Neurology, Society for Neuro-Oncology, Brain Tumor Epidemiology Consortium, and Children’s Oncology Group. She also serves on the Medical Advisory Board for the Make-A-Wish Foundation.
During her off time, Dr. Partap is a passionate traveler, history buff, and oenologist. She enjoys cheering for the St. Louis Cardinals and the Stanford Cardinal, tennis, and hot yoga.
Dr. Brenda Porter is Professor of Neurology at Stanford University. She received her M.D. and Ph.D. from Washington University in St. Louis. She traveled east to complete her child neurology fellowship at the Children’s Hospital of Philadelphia. She went on to complete a combined clinical and research fellowship in epilepsy. Dr. Porter developed an interest in difficult to treat epilepsy, with a special focus on children with neuronal developmental disorders leading to epilepsy such as tuberous sclerosis and focal cortical dysplasia. Her clinical research focuses on improving outcomes in epilepsy surgery by better defining the epileptic network using a variety of intracranial EEG features. She enjoys working in her lab studying the molecular and cellular changes that contribute to the development of epilepsy. Her research has shown that suppression of CREB a transcription factor can decrease the severity of epilepsy and is hoping to expand on this finding and someday turn her research findings into a therapeutic strategy for preventing epilepsy.
She enjoys teaching students in small groups or one-on-one in the clinic. An especially enjoyable afternoon is a lively discussion while reading EEGs with the epilepsy fellows. She is director of the Stanford Tuberous Sclerosis Clinic and medical director of the EEG lab at Lucile Packard. Currently she sits on the NIH Neuroscience Training (NST-1) study section and has helped CURE and the Tuberous Sclerosis Alliance with their grant reviews. Active in the American Epilepsy Society and the Child Neurology Society, she has served on numerous committees over the years.
Dr. Porter spends her evenings collaborating on family meals, including homemade desserts, with her husband Ben, and her children, Emily and Evan. Luckily, she also likes to take long walks and swim to counteract her love of pie.
Dr. Lindsey Rasmussen is a Clinical Assistant Professor of Pediatrics (Critical Care Medicine) and Neurology. As the Co-Director of Pediatric Neurocritical Care, her focus is the merging of neurologic monitoring, care, and prognostic efforts with critically ill patients and complex medical problems. Dr. Rasmussen received her B.A at Miami University of Ohio, and M.D at the Medical College of Wisconsin. She completed her pediatrics residency at Children’s National Medical Center in Washington D.C., and subsequently her pediatric critical care fellowship at Johns Hopkins Hospital in Baltimore. Following her integral involvement in the pediatric neurocritical care program at Johns Hopkins Bloomberg Children’s Center, she was recruited to start a neurocritical care program at the University of Louisville.
Dr. Rasmussen joined the Stanford team in 2018. Her clinical and research interests are in inflammation following traumatic brain injury, outcome prediction after cardiac arrest, and neuro-monitoring in the pediatric intensive care setting. She is an active member of the Pediatric Neurocritical Care Research group as part of the Pediatric Acute Lung Injury and Sepsis Investigators as well as of the Society of Critical Care Medicine and the American Academy of Pediatrics. Dr. Rasmussen is additionally involved in the Stanford Child Advocacy Group.
Outside work, Dr. Rasmussen is an enthusiastic traveler and live music aficionado. She enjoys time with her family and friends, hiking bay area trails, and the vast culinary options of San Francisco.
Dr. Maura R.Z. Ruzhnikov is Clinical Assistant Professor of Neurology at Stanford. She received her B.S. at the University of California, Santa Barbara, and M.D. at New York University School of Medicine. She completed her pediatrics and neurology residencies at the University of California, San Francisco. Dr. Ruzhnikov then completed further specialization with a fellowship in clinical medical genetics at Stanford University.
Dr. Ruzhnikov joined the faculty at Stanford in 2017 and has expertise in neurogenetics. She focuses on in the diagnosis and management of rare neurogenetic and neurometabolic disorders, with a particular interest in severe epilepsy syndromes, leukodystrophies, and neurotransmitter disorders. She runs a Neurogenomics and Neurodegenerative Disorders Clinic along with Dr. Van Haren and genetic counselor Elise Brimble, M.S., as well as a Neurometabolic Disorders Clinic with Dr. Greg Enns in Medical and Biochemical Genetics.
Dr. Ruzhnikov has two young daughters who rarely sleep, but when she gets the chance, she and her husband love to travel, admire art, and very occasionally go running or hiking. They also very much enjoy coffee.
Dr. Emily Spelbrink is Clinical Assistant Professor of Neurology at Stanford University. Dr. Spelbrink received her B.S. at Emory University in Atlanta, and then her M.D. and Ph.D. degrees through the Medical Scientist Training Program at the University of California San Diego. She completed her pediatrics residency at Harbor UCLA, followed by child neurology residency at Stanford, and pediatric epilepsy fellowship at the University of California, San Francisco. Her interests in learning and memory were extended by Ph.D. research in these areas, and continue to fuel her interests in brain development and epileptic encephalopathies as she treats epilepsy patients.
Dr. Spelbrink joined the faculty at Stanford in 2016 as a child neurologist and epileptologist. She sees outpatients primarily at California Pacific Medical Center, in addition to inpatient and EEG service and teaching at Stanford.
When not at work, Dr. Spelbrink enjoys travel, time and space in nature (hiking, running, backpacking, camping), reading, knitting, yoga, and being with close friends and family.
Dr. Lawrence Steinman is the George A. Zimmerman Professor of Neurology and Neurological Sciences; Professor of Pediatrics and, by courtesy, Genetics; and Chair of the Multidisciplinary Program in Immunology. A graduate of Harvard Medical School, he has been on the faculty at Stanford since 1980.
During that time, Dr. Steinman has taken several therapies from the bench to the bedside. He has developed two antigen specific therapies, using DNA vaccines for multiple sclerosis and type 1 diabetes. Steinman was the senior author on a seminal paper reported in Nature in 1992, reporting the key role of a4b1 integrin in brain inflammation. Pre-clinical studies with a monoclonal antibody to a4b1 integrin reversed paralysis in an animal model of multiple sclerosis, which lead to the clinical development of the drug natalizumab (Tysabri). His current research focuses on what provokes relapses and remissions in multiple sclerosis, the nature of the genes that serve as a brake on brain inflammation, and the quest for a vaccine against multiple sclerosis.
Dr. Steinman was awarded the John M. Dystel Prize in 2004 for his research on multiple sclerosis, by the American Academy of Neurology and the National Multiple Sclerosis Society. Twice he has been awarded a Javits Neuroscience Award by the United States Congress and the NIH. In 2009 he was elected a member of the National Academy of Sciences and the National Academy of Medicine. In 2011 he was awarded the Charcot Prize for lifetime achievement in multiple sclerosis research.
Dr. Steinman still manages to find time to attend on the neurology service at Lucile Packard Children's Hospital, where the residents applaud his teaching. He also organized a course on the Brain and the Immune system that was honored as Stanford Graduate for Outstanding Teaching. Outside lab and hospital, he is an avid traveler and ardent Stanford basketball fan with season tickets.
Dr. Carolina Tesi Rocha is a Clinical Associate Professor in Neurology at Stanford University. She received her B.A and M.D. from University of Buenos Aires, Argentina, where she completed her residency in pediatrics and neurology. In 2001, she moved to the United States to complete an international fellowship in neuromuscular disorders, involving basic and clinical research at Children’s National Medical Center in Washington, DC. After five years of working actively in the neuromuscular field, she decided to become board certified in the US and completed her internship in pediatrics at Georgetown University Hospital and a child neurology fellowship at Children’s National Medical Center. After that fellowship, Dr. Tesi Rocha was awarded a K12 Neurological Sciences Academic Development Award through the NINDS at NIH. She became the director of the neuromuscular program at Children’s. In 2013 she was recruited to Stanford University to join the expanding neuromuscular division.
Dr. Tesi Rocha’s major research interest is to develop novel treatments for neuromuscular disorders including muscular dystrophy, spinal muscular atrophy and congenital myopathies. She is an active member of the American Academy of Neurology, Child Neurology Society, World Muscle Society, and the American Association of Neuromuscular and Electrodiagnostic Medicine.
Outside work, Dr. Tesi Rocha enjoys spending time with friends and family, going to the beach, running, and hiking. She also has a passion for cooking and cheering her home soccer (football) team: River Plate. She lives with her husband Sergio and has two children, Juani, a college student in Buenos Aires who visits regularly during school breaks, and younger sister Sophia, a student in Santa Clara.
Dr. Keith Van Haren is an Assistant Professor of Neurology at Stanford University. He spent most of his life in Catholic schools, eventually receiving his B.A. in Chemistry at the College of the Holy Cross. Following graduation, he spent a year in the Jesuit Volunteer Corps enlisted as a mental health case manager in western Montana. Dr. Van Haren originally intended to save the world as a primary care doctor when he enrolled for his M.D. at the University of Rochester, but stumbled upon oligodendrocytes and neurology during a medical student research fellowship. Since that time, he has focused his efforts on saving myelin, a more feasible and still very interesting task.
Dr. Van Haren completed his pediatrics residency at Massachusetts General Hospital and his neurology training at Stanford. He now runs two multidisciplinary clinics at LPCH. In the White Matter Clinic, he and Dr. Gregory Enns, Associate Professor of Genetics & Metabolism, see patients from around the country with a wide range of genetic disorders of myelin (e.g., X-linked adrenoleukodystrophy). In the Neuroinflammation Clinic, he and Dr. Jennifer Frankovich, Assistant Professor of Rheumatology, treat children with a wide range of inflammatory disorders of the nervous system (e.g., multiple sclerosis).
Dr. Van Haren completed his post-doctoral work in the Stanford laboratories of Larry Steinman and Bill Robinson, where he studied the role autoantibodies in neuroinflammation. His current laboratory work is focused on the role of monocytes and microglia in X-linked adrenoleukodystrophy and multiple sclerosis while his clinical research is focused on developing preventive strategies to reduce serious medical complications among leukodystrophy patients. He recently helped found the first leukodystrophy consortium in North America. His research has been supported by grants from the Lucile Packard Foundation for Children’s Health, the Child Neurology Foundation, and the National Institutes of Health.
His interests outside medicine include skiing, traveling, and discussing the country’s education crisis with his wife, Mai, a kindergarten special education teacher and behavioral therapist. Their young daughter and dog, Vinnie, join them for most of their travels and some of their conversations.
Dr. Jo Wallace is a Clinical Assistant Professor in Neurology at Stanford University. Dr. Wallace joined the Division of Child Neurology in 2015 as a Bass Society and Sobrato-Brisson Faculty Scholar. She is a pediatric neuropsychologist who provides assessments for both research and clinical based practice with neuro-oncology patients. Dr. Wallace collaborates on research studies with Stanford pediatric faculty and the international medical field focused on the impact of neurological conditions on neurocognitive functioning and potential cognitive interventions. She has a specialization in art therapy which she utilizes during the assessment process to help engage patients and bring a deeper understanding of the social and emotional well-being of the child.
Dr. Wallace received her B.A. from Loyola University, her M.A. from Notre Dame de Namur University, and her Ph.D. in psychology from Palo Alto University. She completed her internship training at Children’s Hospital Orange County. She provided art therapy to pediatric oncology and hematology patients at Stanford Children’s Hospital for over 10 years. Dr. Wallace has also been an adjunct professor for the master and doctoral psychology programs at Notre Dame de Namur University for over 15 years where she taught and mentored graduate students.
Outside of work, Dr. Wallace can be found chasing her first hole-in-one on the golf course, seeking the perfect wave when surfing the coast of California, or trying to master a pose in her yoga practice.
Dr. Courtney Wusthoff is an Associate Professor of Neurology and by courtesy, Pediatrics (Neonatal and Developmental Medicine) at Stanford University. She is the Neurology Director for the Neurology Neonatal Intensive Care Unit and the Director of Neurocritical Care at Lucile Packard Children's Hospital. She received her B.A. in neuroscience and behavior at Columbia University in New York, her M.D. at the University of California, San Francisco, and her M.S. at Stanford University. Dr. Wusthoff completed her pediatrics residency at Children's Hospital Oakland, and her neurology and neurophysiology training at the Children's Hospital of Philadelphia. After her fellowship, Dr. Wusthoff served as Consultant in Perinatal Neurology at the Hammersmith Hospital and Imperial College in London. She is board certified in pediatrics, child neurology, epilepsy, and clinical neurophysiology.
Dr, Wusthoff leads the neonatal neurology and neurocritical care clinical and research teams. She also is a member of the pediatric epilepsy group, with a focus on the care of newborns and infants with seizures. Her clinical and research interests include neonatal seizures, brain monitoring during critical illness, and medical ethics.
Outside of the hospital, Dr. Wusthoff enjoys travelling, cooking and discovering new things. She is a California native who is happiest at the beach.
Lindsay Chromik, MS
Clinical Research Coordinator
Lindsay has been a Clinical Research Coordinator at Stanford since 2011, and she’s been part of the Child Neurology team since 2019. She has a background in counseling psychology and is especially interested in working with young children and the neuropsychological implications of the disorders the team researches.
Christina Frater, BS
Clinical Research Coordinator Associate
Christina Frater joined Stanford Medicine in June 2020 after earning her Bachelor of Science in psychobiology and society and genetics at UCLA. While there, Christina conducted clinical research on the implementation and efficacy of trauma and resilience-informed care in the NICU. Within child neurology, she is the clinical research coordinator on a natural history study of a rare neurogenetic disease known as NGLY1 deficiency.
Clinical Research Coordinator
Kerry joined the Child Neurology team in 2020, and works primarily on TMS-EEG and EEG studies of pediatric epilepsy. She graduated in 2015 from Wesleyan University with a BA in Economics and Italian Studies. Prior to joining Stanford School of Medicine, she worked as a public health journalist in New Orleans, and as a research assistant within the Affective Cognitive Neuroscience and D'Esposito Labs at University of California, Berkeley, studying reward, decision-making and the neural correlates of Autism Spectrum Disorder using fMRI. Kerry's goal is to pursue a doctorate in cognitive neuroscience.
Senior Clinical Research Coordinator
Sweta Patnaik joined the Division of Child Neurology May 2016. She comes with over 16 years of experience working with both pediatric and adult population on various clinical research studies in the departments of Psychiatry, Neurology and Neurosurgery. As a clinical researcher, Sweta enjoys contributing to the advancement of healthcare and working closely with Principal Investigators, sponsors, and clinical research staff who are committed and motivated towards patient care.
In her spare time, she enjoys spending time outdoors and listening to music.
Prathyusha Teeyagura, MS
Research Data Analyst I
A graduate of Haub School of Business at Saint Joseph’s University, Prathyusha received her Masters of Science in Business Intelligence & Analytics after completing her undergrad in Bachelors of Dental Surgery in India. She joined Stanford Child Neurology department in 2020 and started collaborating with Neurocritical care, Epilepsy, Neuro-PICU teams in design and development of advanced data pipelines for Quality improvement and research projects. And she facilities the unique interaction of clinical research database, Quality assurance and Quality improvement.
Outside of work, Prathyusha enjoys hiking, camping, travelling, and spending a lot of time with close friends while exploring new places.
Clinical Research Coordinator Associate
I joined Child Neurology in August of 2019. I graduated from the University of Oregon with a Bachelor of Science in Psychology in 2017, and started working at Stanford School of Medicine in 2018 with Cardiovascular Medicine as a CRCA. The projects that I am mainly apart of are industry sponsored clinical trials involving drug treatments for genetic Epilepsy disorders. I hope to attend Graduate School for a Master’s in Genetic Counseling- an interest from which I found through working in Child Neurology. I love working with the PIs and fellow coordinators who make the job even more enjoyable. In my spare time I play soccer and practice yoga as well as spending time with my friends.